Carret Asset Management LLC Purchases 51 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Carret Asset Management LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,586 shares of the healthcare conglomerate’s stock after purchasing an additional 51 shares during the quarter. Carret Asset Management LLC’s holdings in UnitedHealth Group were worth $3,467,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $26,000. Robbins Farley bought a new position in shares of UnitedHealth Group during the third quarter worth about $25,000. CGC Financial Services LLC raised its position in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC raised its position in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA grew its stake in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $1.12 during mid-day trading on Wednesday, reaching $487.30. 3,722,296 shares of the company’s stock were exchanged, compared to its average volume of 4,532,990. The business’s fifty day simple moving average is $487.49 and its 200 day simple moving average is $514.76. The firm has a market capitalization of $449.26 billion, a PE ratio of 29.79, a P/E/G ratio of 1.42 and a beta of 0.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period last year, the company posted $6.26 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.54%. UnitedHealth Group’s payout ratio is presently 45.97%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Piper Sandler raised their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Barclays raised their target price on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Stephens reaffirmed an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. TD Cowen reduced their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Finally, Truist Financial reissued a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.